AME

Business profile & competitive position

AMETEK, Inc. operates in the Industrials sector within the Electrical Equipment & Parts industry. The company describes itself as a leading global manufacturer of electronic instruments and electromechanical devices, organized around two operating groups. The Electronic Instruments Group (EIG) designs and manufactures advanced analytical, test and measurement instruments for process, aerospace, power and industrial markets. The Electromechanical Group (EMG) supplies precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects to aerospace and defense, medical, automation and other industrial markets.

Profitability metrics suggest a defensible competitive position. AMETEK reports a net margin of 20.0% and a return on equity (ROE) of 14.5%. A 20% net margin is materially above what is typical for many industrial manufacturers, pointing to pricing power, installed-base aftermarket revenue, or a portfolio tilt toward high-specification, difficult-to-replace components. The 14.5% ROE indicates the business is converting equity capital into earnings at a rate that comfortably exceeds the cost-of-capital threshold many investors associate with value creation. A beta of 0.99 sits almost exactly at market-average volatility, implying AMETEK's equity risk profile is not strongly leveraged to cyclical swings relative to the broader S&P 500.

Financial posture

AMETEK's current market capitalization is $55.5 billion, with shares recently trading at $242.08. The stock carries a price-to-earnings (P/E) ratio of 35.2, placing it at a clear premium to the broader industrials complex. That multiple implies investors are pricing in sustained growth and above-average returns on capital rather than a deep-value re-rating. Against that backdrop, the 20.0% net margin and 14.5% ROE provide the fundamental justification for the valuation, but they also set a high bar: the company needs to keep expanding margins or earnings per share at a pace that supports the premium.

On the latest reported full-year basis, 2025 sales reached $7,401.1 million, up 6.6% from 2024, and diluted earnings per share were $6.40, up 7.9%. AMETEK also recorded record operating income, net income, orders and backlog in 2025. At the current price, the shares trade above the $158 intrinsic-value estimate that was the subject of a September 16, 2026 GuruFocus DCF-focused headline, a gap that has helped fuel recent valuation debate. Technical snapshot figures show a relative strength index (RSI) of 54.1 and a 50-day exponential moving average of $239.03, suggesting the stock is hovering near its short-term trend.

Strategic priorities & outlook

AMETEK's most recent 10-K filing outlines a strategy built on four pillars. The first is the AMETEK Growth Model, which targets high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow generation and a superior return on total capital. The second is Operational Excellence, executed through lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens and the increased use of digitalization and artificial intelligence.

The third pillar is acquisitions. From 2021 through December 31, 2025, AMETEK closed 15 acquisitions representing roughly $1.8 billion in annualized sales. In 2025 alone, the company deployed $933.2 million in cash, net of cash acquired, to buy Kern (high-precision machining and optical inspection solutions) and FARO Technologies (3D measurement and imaging solutions). The fourth pillar is global expansion, with best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia positioned for customer proximity and international growth. Geographically, 52% of EIG's net sales and 42% of EMG's net sales in 2025 went to customers outside the United States. As of December 31, 2025, AMETEK employed approximately 22,500 people.

Macro & geopolitical exposure

As an Electrical Equipment & Parts company serving aerospace, defense, power, process, medical and automation markets, AMETEK carries the macro sensitivities common to advanced manufacturing. Demand is tied to capital spending cycles in industrials, commercial aerospace build rates and defense procurement budgets. Because roughly half of segment sales are booked outside the United States, revenue is exposed to currency translation effects, particularly a stronger U.S. dollar.

The global manufacturing footprint in China, Czechia, Malaysia, Mexico and Serbia introduces trade-policy and tariff risk, as well as supply-chain complexity for components and specialty metals. Tighter U.S. export controls on defense-adjacent technologies could affect aerospace and defense sales, while medical-device customers may face regulatory changes in major markets. Interest rates are another variable: higher rates raise the cost of debt for acquisitions and can pressure customer capital budgets, while lower rates can make acquisition financing cheaper for AMETEK's roll-up strategy.

Recent developments

Recent news flow has mixed thematic and valuation angles. On September 17, 2026, Fool.com published the headline "NASA's New Moon Base Contract Could Be an Out-of-This-World Opportunity for This Under-the-Radar Nuclear Power Stock," suggesting that at least some market commentary is linking AMETEK to aerospace-related opportunities. A day earlier, on September 16, 2026, GuruFocus ran "Is AME Overvalued? DCF Says Worth $158," directly questioning whether the company's premium valuation is supported by discounted-cash-flow math.

On September 4, 2026, Seeking Alpha covered "Baron SMID Cap ETF Q2 2026 Portfolio Activity," giving a window into institutional sentiment and fund positioning in the name. Separately, a September 3, 2026 Zacks article asked "Why Is Ametek (AME) Down 8.5% Since Last Earnings Report?", highlighting that the stock has experienced a measurable pullback despite what has been an otherwise consistent earnings track record.

Earnings behavior & post-earnings drift

AMETEK's earnings delivery has been remarkably consistent. Over the last eight reported quarters, the company has beaten consensus estimates 8 out of 8 times, for a 100% beat rate, with an average earnings surprise of 4%. Despite that reliability, the average 5-day price move in the five trading days after earnings across those quarters is just 0.46%, classified as "flat" drift. This pattern suggests that beat expectations may already be embedded in the stock price by the time results are released.

The four most recent reports illustrate the dynamic. On August 4, 2026, AMETEK reported EPS of $2.09 against a $1.99 estimate, a 5.0% surprise; the stock rose 0.28% the next day and 0.89% over the following five days. On April 30, 2026, EPS of $1.97 beat a $1.90 estimate by 3.7%, yet the stock fell 2.13% the next day and 0.33% over five days. On February 3, 2026, EPS of $2.01 beat a $1.94 estimate by 3.6%, but the stock dipped 0.48% the following session before rising 1.83% over five days. On October 30, 2025, EPS of $1.89 beat a $1.76 estimate by a larger 7.4% surprise, producing a 1.91% next-day gain but a 0.54% five-day decline. The next scheduled report is October 29, 2026, before the market open, with a consensus EPS estimate of $2.11.

For a deeper dive into how institutional analysts are interpreting AMETEK's premium valuation, acquisition strategy and upcoming October 29, 2026 earnings report, review the full institutional verdict on the ticker page.